Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats
Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats
复制标题
DOI:
10.1385/bter:83:3:251
复制
发表时间:
2001-12-01
影响因子:
3.9
通讯作者:
Bianchi, MLP
中科院分区:
文献类型:
--
作者:
Camargo, SMR;Francescato, HDC;Bianchi, MLP
Cisplatin (c-DDP) is a widely used antineoplastic drug whose main side effect is nephrotoxicity. Selenium, administered intravenously or intraperitoneally, has been shown to provided protection against c-DDP-induced nephrotoxicity in rats. in the present study, the protective effect of orally administered sodium selenite on c-DDP toxicity was further examined. Animals treated with c-DDP alone showed increased urinary volume, decreased creatinine clearance (GFR), and a rise in urinary N-acetyl-(beta -n-glucosaminidase) (NAG) isoenzyme B activity. When sodium selenite as given prior to c-DDP, rats showed less GFR decline, delayed urinary volume increases, and no urinary NAG isoenzyme B activity increment. It is suggested that a single oral dose of sodium selenite given prior to c-DDP administration, although not preventing deterioration of renal function, partially protects rats from early proximal tubular injury.